BioSpace News Archive

GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVert™ contrast minimization devices, complemented by GE Healthcare’s range of iodinated x-ray contrast media, offer healthcar

Healthcare payer services are services that are outsourced by healthcare insurance payers and providers.

Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that it will report second quarter 2020 financial results on Thursday, August 6, 2020 , before the market opens.

On July 28, 2020, ATC Healthcare Services, LLC (“ATC”), one of the nation’s preeminent medical staffing firms, and Rymedi, Inc. (“Rymedi”), a leader in the field of digitally connected testing and tracking, entered into a partnership to provide a turnkey COVID-19 testing solution.

- Additional capital to accelerate clinical development of IW-6463 in two CNS indications and olinciguat for sickle cell disease - - IW-6463 translational pharmacology and olinciguat STRONG Phase 2 top line clinical study results remain on track for late summer and late Q3 2020, respectively -

A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and available infrastructures.

In vitro diagnostics and laboratory developed tests for autoimmune diseases are a key part of the global healthcare sector and are likely to account for a significant share in the same in the coming years due to the rising investment in the healthcare sector from various channels.

Prevalence of a sedentary lifestyle is one of the major causes of musculoskeletal diseases as it causes stiffness in the bones, states TMR Research in a research report.

Experiments in the field of biology includes the use of drugs or gene editing or implants which improve the capabilities or qualities of living organisms.

The growing incidence of bacterial infections has emerged as a source of growth within the global bacteriophage market.